Clinical Trials Browser

Phase 3 × Smoldering Multiple Myeloma × daratumumab × Clear all

NCT07393282 2026-03-16

LINKER-SMM2

Phase 3 Not yet recruiting

Smoldering Multiple Myeloma, Multiple Myeloma

NCT03937635 2026-03-02

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Phase 3 Recruiting

Smoldering Multiple Myeloma